|
KIAA1586 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.66970026483204E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72379999163752E-09 |
| Normal-vs-Stage2 |
1.52639999528859E-08 |
| Normal-vs-Stage3 |
4.22169965652586E-10 |
| Normal-vs-Stage4 |
2.29649632643714E-11 |
| Stage1-vs-Stage2 |
9.338200E-01 |
| Stage1-vs-Stage3 |
2.881200E-01 |
| Stage1-vs-Stage4 |
1.491870E-02 |
| Stage2-vs-Stage3 |
5.392600E-01 |
| Stage2-vs-Stage4 |
1.051750E-01 |
| Stage3-vs-Stage4 |
2.138800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.50890025105855E-10 |
| Normal-vs-AfricanAmerican |
2.00679999950992E-07 |
| Normal-vs-Asian |
3.10320003027442E-09 |
| Caucasian-vs-AfricanAmerican |
7.945800E-01 |
| Caucasian-vs-Asian |
7.940800E-01 |
| AfricanAmerican-vs-Asian |
6.854400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01299976687608E-10 |
| Normal-vs-Female |
1.03139996543433E-09 |
| Male-vs-Female |
2.351400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.97619995315301E-09 |
| Normal-vs-Age(41-60Yrs) |
3.83679976678764E-10 |
| Normal-vs-Age(61-80Yrs) |
3.50769968626707E-10 |
| Normal-vs-Age(81-100Yrs) |
1.004360E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.704400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.526000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.125000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.715000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.045400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.384600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.317980E-01 |
| Classical-VS-Follicular |
1.257160E-01 |
| Classical-VS-Other |
5.540600E-01 |
| Classical-VS-Normal |
7.3588000137903E-09 |
| Tall-VS-Follicular |
6.302600E-01 |
| Tall-VS-Other |
8.437600E-01 |
| Tall-VS-Normal |
8.84549988811045E-10 |
| Follicular-VS-Other |
9.507200E-01 |
| Follicular-VS-Normal |
1.03080000091182E-09 |
| Other-VS-Normal |
9.9626999999991E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.38180039527458E-10 |
| Normal-vs-N1 |
4.12120004789074E-09 |
| N0-vs-N1 |
9.173800E-01 |
|
|
